Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.
about
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH RegistryLipoprotein (a): impact by ethnicity and environmental and medical conditionsMicrosomal transfer protein inhibitors, new approach for treatment of familial hypercholesterolemia, review of the literature, original findings, and clinical significance.Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".
P2860
Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Risk stratification of patient ...... emia in a multi-ethnic cohort.
@ast
Risk stratification of patient ...... emia in a multi-ethnic cohort.
@en
type
label
Risk stratification of patient ...... emia in a multi-ethnic cohort.
@ast
Risk stratification of patient ...... emia in a multi-ethnic cohort.
@en
prefLabel
Risk stratification of patient ...... emia in a multi-ethnic cohort.
@ast
Risk stratification of patient ...... emia in a multi-ethnic cohort.
@en
P2093
P2860
P356
P1476
Risk stratification of patient ...... emia in a multi-ethnic cohort.
@en
P2093
Jiri Frohlich
Masoud Yousefi
Matthew D Allard
Ramesh Saeedi
P2860
P2888
P356
10.1186/1476-511X-13-65
P577
2014-04-08T00:00:00Z
P5875
P6179
1023116208